im3D is applying CAD methodologies for use in screening and diagnosing a variety of cancer pathologies including breast cancer. Its CAD-BREAST MRI is reportedly an innovative diagnostic and therapy monitoring prototype that applies CAD precision and accuracy to DCE-MRI results. Not only do im3D’s proprietary CAD algorithms reportedly help improve the specificity of DCE-MRI, CAD-BREAST MRI is an intelligent system that automatically calculates and processes the diagnostic parameters used to identify (morphologically) and diagnose a potential tumor in an objective, precise and consistent manner. In other words, CAD-BREAST MRI is able to quantify internationally-accepted measurement standards to deliver not only objective and quantifiable scores but also a mathematical probability of the type of tumor (malignant or benign).
Technology | November 13, 2008
im3D Applies CAD to Sceening for Breast Cancer
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Videos | Artificial Intelligence | December 19, 2017
A post-game roundup by ITN Contributing Editor Greg Freiherr and ITN Editor Dave Fornell on the key trend of artifici
News | Mammography | December 14, 2017
December 14, 2017 — iCAD Inc.
Technology | Computed Tomography (CT) | November 28, 2017
Infervision is introducing what it calls the first and only artificial intelligence (AI) platform to help radiologists...
News | Computer-Aided Detection Software | November 10, 2017
November 10, 2017 — Imaging for Women, a leading radiology center in Kansas City, Mo., announced it is now using iCAD
News | Artificial Intelligence | November 09, 2017
Deep learning imaging analytics company Zebra Medical Vision announced that all its current and future radiology...
News | Computer-Aided Detection Software | November 08, 2017
November 8, 2017 — CureMetrix, a company developing...
News | Computer-Aided Detection Software | October 27, 2017
iCAD Inc. announced that its PowerLook Tomo Detection has been named 2017 Product of the Year by the New Hampshire High...
News | Lung Cancer | September 13, 2017
Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for...
Technology | Lung Cancer | August 28, 2017
20/20 GeneSystems Inc. recently released in China what is believed to be the world’s first machine learning algorithm...